Philips, established in 1891 and headquartered in Amsterdam, Netherlands, is a global leader in health technology, committed to improving people's health and well-being through meaningful innovation. The company's portfolio includes diagnostic imaging, image-guided therapy, patient monitoring, health informatics, and consumer health and home care products. Philips aims to improve 2.5 billion lives per year by 2030, including 400 million in underserved communities. Recognized for its commitment to sustainability and social responsibility, Philips has been named a top employer by Forbes and ranked as the highest medical technology company among Clarivate's Top 100 Global Innovators in 2025.
Royal Philips announced it will introduce its latest differentiating, AI-enabled innovations to improve patient care at the European Congress of Radiology (ECR) annual meeting in Vienna.
RF coils are an essential part of every MRI scan. The new ultra-lightweight coils provide exceptional flexibility, significant reduction in patient setup time and optimization.
BlueSeal MR Mobile’s unique magnet technology advances patient outcomes and access to care with high-quality diagnostic imaging and enhanced workflows.
Visual Patient Avatar translates the wealth of information from Philips IntelliVue patient monitors into visual patient data using an avatar that displays colour, shape and animation.
Offering surgeons greater flexibility, control, and personalization in C-arm operation and image acquisition, Philips’ new Zenition 30 reduces dependency on technician support for a wide variety of minimally invasive procedures.
The latest extension of Masimo and Philips’ ongoing collaboration will help enable clinicians to make quick and informed decisions without the need for additional monitoring equipment.